Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Clinical Utility
100%
Dyslipidemia
100%
Bile Acid Sequestrants
100%
Scientific Review
100%
Low-density Lipoprotein Cholesterol (LDL-C)
23%
Bile Acids
23%
Statins
15%
Monotherapy
15%
Colesevelam Hydrochloride
15%
Intestine
7%
United States
7%
Cholesterol
7%
Coronary Artery Disease
7%
Lipid-lowering
7%
Mechanism of Action
7%
Combination Therapy
7%
Therapeutic Effect
7%
Drug Interactions
7%
Hypercholesterolemia
7%
Cholesterol Reduction
7%
Disease-associated
7%
Safety Profile
7%
Type 2 Diabetes Mellitus (T2DM)
7%
Cholestyramine
7%
Intolerant
7%
Niacin
7%
Lipid-lowering Agents
7%
Sequestration
7%
Enterohepatic Circulation
7%
High Capacity
7%
Cholesterol Absorption Inhibitor
7%
Metabolic Disorders
7%
High-dose Statin
7%
Fibrates
7%
Complementary Mechanism
7%
Bile Acid Metabolism
7%
Coronary Artery Calcium Progression
7%
Synthetic Pathway
7%
Polymer Structure
7%
Low-dose Statin
7%
Colestipol
7%
Systemic Medications
7%
Non-statins
7%
Bile Acid Pool
7%
Sequestrant
7%
Enhanced Specificity
7%
Pharmacology, Toxicology and Pharmaceutical Science
Dyslipidemia
100%
Bile Acid Sequestrant
100%
Bile Acid
38%
Low Density Lipoprotein Cholesterol
23%
Statin (Protein)
23%
Coronary Artery Disease
15%
Monotherapy
15%
Colesevelam
15%
Combination Therapy
7%
Disease Exacerbation
7%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
7%
Therapeutic Effect
7%
Drug-Drug Interaction
7%
Hypercholesterolemia
7%
Colestyramine
7%
Nicotinic Acid
7%
Antilipemic Agent
7%
Fibric Acid Derivative
7%
Colestipol
7%
Sequestering Agent
7%
Maturity Onset Diabetes of the Young
7%